Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Marsh & Mclennan Companies (MRSH) EBITDA (2016 - 2025)

Marsh & Mclennan Companies (MRSH) has disclosed EBITDA for 17 consecutive years, with $1.2 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA rose 896.73% year-over-year to $1.2 billion, compared with a TTM value of $3.7 billion through Dec 2025, up 218.26%, and an annual FY2025 reading of $6.2 billion, up 6.98% over the prior year.
  • EBITDA was $1.2 billion for Q4 2025 at Marsh & Mclennan Companies, up from -$117.0 million in the prior quarter.
  • Across five years, EBITDA topped out at $1.8 billion in Q2 2025 and bottomed at -$624.0 million in Q4 2022.
  • Average EBITDA over 5 years is $558.9 million, with a median of $626.0 million recorded in 2023.
  • Peak annual rise in EBITDA hit 896.73% in 2025, while the deepest fall reached 200.0% in 2025.
  • Year by year, EBITDA stood at -$260.0 million in 2021, then crashed by 140.0% to -$624.0 million in 2022, then soared by 276.76% to $1.1 billion in 2023, then tumbled by 113.87% to -$153.0 million in 2024, then skyrocketed by 896.73% to $1.2 billion in 2025.
  • Business Quant data shows EBITDA for MRSH at $1.2 billion in Q4 2025, -$117.0 million in Q3 2025, and $1.8 billion in Q2 2025.